Jarrett Jennifer bought DMRA
March 30, 2026 · Form 4 insider transaction
Jarrett Jennifer bought 1,500,000 shares of Damora Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,500,000
Price
$0.00
Total value
N/A
InsiderJarrett Jennifer
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 30, 2026
Filing dateApril 1, 2026
Shares owned after1,500,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase shares of common stock of the Issuer. This option will vest as to 25% on March 30, 2027 and in equal monthly installments thereafter through March 30, 2030, subject to the Reporting Person's continued service to the Issuer on each such vesting date.